pr-inside.com
Print

PharmaNewswire.Com Launches with Pharmaceutical News and Press Releases



2008-05-08 00:11:58 -

Pharmaceutical news on drugs, pharmaceutical research and Press release service for the Pharmaceutical Industry


(EMAILWIRE.COM, May 7, 2008) Houston, TX - PharmaNewswire.com
( www.pharmanewswire.com ) launches with pharmaceutical and medical news and press releases. The pharmaceutical news site features breaking news on drugs, pharmaceutical research and press releases from pharmaceutical companies, organizations, individuals throughout the world. Pharmanewswire.Com currently receives XML news feeds from EmailWire.com.

About EmailWire.Com
Emailwire.com™ (www.emailwire.com) is a press release distribution service of GroupWeb Media LLC. Emailwire.com™ uses social networking, co-branding, viral marketing, XML, RSS, FTP feeds and E-mail alerts to distribute press releases to major and none major newswires, vertical and social network news websites, blogs, individual email boxes through opt-in distribution, and to journalists' desktops in the format they choose. EmailWire.Com currently offers unlimited pres release distribution for $499 per year at www.emailwire.com/publications/unlimited_press_release_distribut .. .

About GroupWeb Media LLC
GroupWeb Media LLC ( www.groupweb.com ) is an online media company that specializes in press release distribution, newswire services, news aggregation and dissemination. GroupWeb Media LLC currently has 70 regional and 36 vertical portals that deliver news to targeted audiences.

For PharmaNewswire.Com (www.pharmanewswire.com ), contact GroupWeb Media Staff at 281-6454086.

###

This press release was issued through GroupWeb EmailWire.Com. For more information on unlimited press release distribution for $499/year, go to www.emailwire.com



Autor:
GroupWeb EmailWire.Com
e-mail
Web: http://www.emailwire.com
Telefon: 281-645-4086




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.